Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab

The emergence of new treatments the inflammatory bowel diseases (IBD) raised questions regarding the role of older agents, namely thiopurines.

Source: Digestive and Liver Disease - November 16, 2023 Category: Gastroenterology Authors: Paula Sousa, Marta Patita, Bruno Arroja, Paula Lago, Isadora Rosa, Helena Tavares de Sousa, Paula Ministro, Irina Mocanu, Ana Vieira, Joana Castela, Joana Moleiro, Joana Roseira, Eugenia Cancela, Francisco Portela, Luis Correia, Mafalda Santiago, Sandra D Tags: Alimentary Tract Source Type: research